Markets:

Overview

News

Currencies

International

Treasuries

Biogen Idec (NQ:BIIB)

191.55 +2.56 (+1.35%)

Streaming Delayed Price Updated: 3:26 PM EST, Feb 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Biogen Idec

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

57 58 Next >

(BIIB) - Analyzing Biogen's Short Interest ↗

July 20, 2023

Via Benzinga

Eisai Presents Latest Analysis of Lecanemab’s Effect on Biomarker Changes and Subcutaneous Dosing at The Alzheimer’s Association International Conference (AAIC) 2023

July 19, 2023

From Biogen Inc.

Via GlobeNewswire

Acumen Soars on Alzheimer's Study...Street Sees It Doubling

July 19, 2023

Will the $11.00 level be a double-top ceiling…or can Acumen Pharmaceuticals build momentum and climb towards its $25.00 IPO price?

Via MarketBeat

Topics Initial Public Offering

Is Biogen Stock a Buy Now? ↗

July 19, 2023

The biotech hasn't been the best investment recently.

Via The Motley Fool

Should You Buy the Dip With Biogen Stock Right Now? ↗

July 17, 2023

It's expected to grow, but things might not work out precisely as planned.

Via The Motley Fool

P/E Ratio Insights for Biogen ↗

July 12, 2023

Via Benzinga

Biogen Just Reached a Big Milestone. Why Isn't the Stock Rising? ↗

July 09, 2023

Biogen shares are little changed year to date.

Via The Motley Fool

If You Invested $1000 In This Stock 15 Years Ago, You Would Have $4,900 Today ↗

July 07, 2023

Via Benzinga

These 2 Numbers Should Scare Every Biogen Shareholder ↗

July 16, 2023

There are a couple of pieces of evidence that Biogen's long-term strategy isn't working.

Via The Motley Fool

7 Stocks That AI Says Will Make You a Millionaire by 2025 ↗

July 13, 2023

These seven millionaire-maker stocks are changing hands at deeply undervalued levels. As their growth re-accelerates, so will your portfolio.

Via InvestorPlace

Why Isn't Biogen Stock Soaring After This Major FDA Approval? ↗

July 13, 2023

Is the stock a good contrarian buy?

Via The Motley Fool

Biogen Shares Fall After FDA Approval Of Alzheimer's Drug Leqembi

July 10, 2023

Biogen's shares decline after approval of Alzheimer's treatment Leqembi, which modestly slows cognitive decline. Analysts see hurdles to the rollout.

Via MarketBeat

Mixed Jobs Data; Fed Governors Want More Interest Rate Hikes; US, China Spat Rattles Semiconductor Sector: The Week In The Markets ↗

July 07, 2023

Via Benzinga

What 29 Analyst Ratings Have To Say About Biogen ↗

July 07, 2023

Via Benzinga

What's Going On With Biogen Stock Thursday ↗

July 06, 2023

Biogen Inc (NASDAQ: BIIB) shares were flat in Thursday's after-hours session after falling marginally by 0.31% to $284.99 during

Via Benzinga

Expanded Medicare Coverage For Biogen-Eisai's Leqembi Signals a Turning Point in Alzheimer's Treatment: Analysts ↗

July 07, 2023

The FDA approved a supplemental marketing application for Biogen Inc (NASDAQ: BIIB)-Eisai Co Ltd (OTC: ESALY) supporting the traditional approval of Leqembi (lecanemab-irmb), making it the first and...

Via Benzinga

FDA Approves Biogen's Alzheimer's Drug: Here Are Other Companies With Treatments In The Pipeline ↗

July 07, 2023

The FDA fully approved Biogen Inc.’s (NASDAQ: BIIB) Alzheimer’s treatment Leqembi on Thursday, becoming the first Alzheimer’s antibody treatment to reach full approval.

Via Benzinga

Stock Market Rally Pulls Back As Yields Jump; Tesla, Meta In Focus: Weekly Review ↗

July 07, 2023

Automakers rallied on sales while Meta's Threads had a big launch.

Via Investor's Business Daily

FSLR Stock Alert: The $1 Billion Reason First Solar Is Up Today ↗

July 07, 2023

First Solar (FSLR) stock is rising higher on Friday after the solar energy company announced a $1 billion revolving credit facility.

Via InvestorPlace

Why Is Alibaba (BABA) Stock Up Today? ↗

July 07, 2023

Alibaba (BABA) stock is on the rise Friday as investors react to a few pieces of news considering the Chinese e-commerce giant.

Via InvestorPlace

BIIB Stock Alert: What to Know as FDA Approves Biogen’s Alzheimer’s Drug ↗

July 07, 2023

Biogen (BIIB) stock is in the news Friday after the pharmaceutical company got approval from the FDA for its Alzheimer's drug.

Via InvestorPlace

Stock Futures Dip As Traders Eye Friday Jobs Report: Analyst Says Q3 Returns Hinge More On This Catalyst Than Fed Move ↗

July 07, 2023

Via Benzinga

July 06, 2023

Via Benzinga

FDA Grants Traditional Approval for LEQEMBI® (lecanemab-irmb) for the Treatment of Alzheimer’s Disease

July 06, 2023

From Biogen Inc.

Via GlobeNewswire

3 Biotech Stocks to Make Your ‘Get Rich’ Dreams Come True ↗

July 06, 2023

These high return biotech stocks offer tremendous upside ahead and are likely to soar on the back of several growth drivers

Via InvestorPlace

Biogen's Make-Or-Break Moment Is Here In Alzheimer's Treatment ↗

July 06, 2023

The FDA is expected to announce Thursday whether it has approved or rejected Biogen's Alzheimer's drug.

Via Investor's Business Daily

Biogen Reports New Spinraza Data In Atrophy Patients After Incomplete Response To Novartis' Treatment ↗

July 03, 2023

Biogen Inc (NASDAQ: BIIB) announced new Spinraza (nusinersen) data that were presented at the SMA Research & Clinical Care Meeting

Via Benzinga

New Data at Cure SMA Highlight Potential Benefit of SPINRAZA® (nusinersen) in Infants and Toddlers with Unmet Clinical Needs After Gene Therapy

June 30, 2023

From Biogen Inc.

Via GlobeNewswire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

June 30, 2023

Via Benzinga

Amgen Inc. Dividend Stock Analysis ↗

June 30, 2023

The company has paid a cash dividend to shareholders every year since 2011 and has increased its dividend payments for 13 consecutive years.

Via Talk Markets

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

57 58 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.